ProPhase Labs Inc PRPH

NAS: PRPH | ISIN: US74345W1080 31/05/2024

5,150 USD (+4,25%)

(+4,25%) 31/05/2024

Grafiek ProPhase Labs Inc

Grafiek ProPhase Labs Inc

1 dag1d 4,25%
1 week1w 0,59%
1 maand1m -0,77%
3 maanden3m 12,94%
6 maanden6m 3,73%
1 jaar1j -43,72%
5 jaar5j 71,67%

ProPhase Labs Inc in het nieuws

Toon enkel gratis nieuws

27 april 2023 · COMSovereign Names Bill White, CFE as New Independent Director and Chair of Audit Committee · Persbericht

15 maart 2021 · ProPhase Labs to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call on Wednesday, March 31, 2021 at 4:30 p.m. Eastern Time · Persbericht

9 februari 2021 · ProPhase Labs Begins Advanced, Saliva-based Viral PCR Multiplex-Testing for COVID-19, Influenza A & B, and Other Viruses After FDA Confirmation of Two Emergency Use Authorizations · Persbericht

1 februari 2021 · ProPhase Labs Exceeding Initial Goals as Covid-19 Lab Testing Business Ramps up · Persbericht

29 januari 2021 · ProPhase Labs Announces Opening of Large CLIA Lab Covid Testing Facility in Garden City, New York · Persbericht

21 januari 2021 · ProPhase Labs, Inc. Announces Closing of Public Offering · Persbericht

19 januari 2021 · ProPhase Labs Announces Pricing of Public Offering of Common Stock · Persbericht

15 januari 2021 · ProPhase Labs Announces Proposed Public Offering of Common Stock · Persbericht

5 januari 2021 · ProPhase Labs Announces $5.5 Million Registered Direct Offering of Common Stock and Warrants · Persbericht

Profiel ProPhase Labs Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Huishoudelijke/Persoonlijke Verzorging

Niet-duurzame consumptiegoederen

Werknemers: 53

Aandelen ProPhase Labs Inc

Beurswaarde: 94,25 miljoen USD

Effecten: 19,08 miljoen

Beta: -0,12

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe